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OSASAbstract Background: Split-night polysomnography was introduced to obtain diagnosis and
determine an effective CPAP on a single night that would be convenient and cost effective.
Aim of the study: To evaluate the efﬁcacy of split night CPAP titration in comparison with con-
ventional full night titration in patients with moderate and severe OSAS.
Patients and methods: Matched patients for age, sex, body mass index and disease severity were
enrolled in the study and classiﬁed into two groups either split night or full night group.
Results: Sixty matched patients in each group (full night and split night group) were included in
the study. Regarding sleep parameters, sleep efﬁciency (75.9 ± 15.7 vs. 81.5 ± 10.5, p= 0.024) was
signiﬁcantly shorter, stage 1% was signiﬁcantly higher (22.3 ± 14 vs. 17.9 ± 15.8, p= 0.013) and
REM % (23.9 ± 18.7 vs. 31.3 ± 14.8, p= 0.019) was signiﬁcantly lower during split night CPAP
titration compared to full night titration study. Unsuccessful CPAP titration was signiﬁcantly
higher in split night group than the full night group (30 (50%) vs. 16 (35.5%), p= 0.025). Apnea
hypopnea index >36.4 during diagnostic part and total sleep time at least 2.45 h during CPAP part
of split night titration were identiﬁed as the optimum cut off for successful titration with 73.5%
sensitivity, 43.3% speciﬁcity and 74% sensitivity, 70% speciﬁcity respectively.
Conclusion: Split night sleep study is more commonly associated with unsuccessful CPAP
titration than full night titration but successful titration could be obtained during split night
titration in patients with severe AHI >36.5 event/h.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Obstructive sleep apnea syndrome (OSAS) is the most com-
mon type of sleep-related breathing disorders, its prevalence
ranges from 2% to 4% of the middle-aged population [1].
OSA is a very important diagnosis for physicians to consider
because of its strong association with potential cause of therculosis.
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cardiovascular disease, coronary artery disease, insulin-
resistance diabetes, depression, and sleepiness-related acci-
dents. However despite being a common disease, OSAS is
under recognized by most primary care physicians [2]. In most
laboratories, patients with sleep apnea are evaluated for an
entire diagnostic night followed by a continuous positive air-
way pressure (CPAP) titration night. Due to the presence of
ﬁnancial restrictions and waiting lists, sleep centers could solve
this problem by investigating and treating patients using split
night studies whereby diagnostic polysomnography and
continuous positive airway pressure (CPAP) titration are
accomplished on the same night rather than the standard
two nights polysomnography [3].
In 1997, the American academy of sleep medicine recom-
mended apnea/hypopnea index (AHI) threshold of 40 events/
h or from 20 to 40 events/h in the presence of clinical symp-
toms and marked desaturations that give permission to
undergo split night titration [4]. However new techniques for
measuring and scoring sleep disordered breathing events have
been administered which may greatly inﬂuence the severity of
AHI [5,6], thus the threshold of AHI needed for CPAP titra-
tion, also may not be considered accurate for doing split–night
titration.
Furthermore, it is of concern that split-night polysomnog-
raphy cannot accurately assess sleep architecture and sleep dis-
order severity, and also may not be adequate for optimum
titration while rapid eye movement (REM) sleep may not be
present adequately in a split-night protocol [7,8]. There are
few studies regarding the efﬁcacy of CPAP titration during
split night sleep study.Aim of the study
To evaluate the efﬁcacy of split night CPAP titration in com-
parison with conventional full night titration in patients with
moderate and severe OSAS.
Patients and methods
This randomized parallel study was carried at the sleep labora-
tory of the Chest department of Assiut University hospital. An
informed written consent was obtained from all the patients
enrolled in the study. The study was approved by the Faculty
of Medicine Ethics Committee, Assiut University.
Patient selection
We included adult patients with moderate and severe OSAS
(diagnosed by polysomnography as total AHI P15). OSAS
patients associated with other pulmonary diseases or patients
who developed claustrophobia or with technical error during
CPAP titration were excluded from the study.
Study design
Over a two year period, we assessed patients coming for
polysomnography clinically, radiologically by chest X-ray
and functionally (by spirometry and arterial blood gases).
Patients matched with the inclusion criteria were enrolled inthe study. Patients were then randomized to either undergo
titration in the same diagnostic night or prepared for second
full night attended CPAP titration sleep study. Patients were
matched for sex, age (±10 yrs), body mass index (BMI)
(±5 kg/m2), and severity. Matched patients were enrolled
in the study and classiﬁed into two groups either split night
or full night group.
Polysomnography and CPAP titration
Patients included in the study underwent polysomnography
(Sleep Lab Pro, Jaeger, VIASYS Healthcare Hoechberg,
Germany). The polysomnogram in each group monitored elec-
troencephalogram (C3-A2, C4-A1), electro-oculogram, elec-
tromyogram of the chin, electrocardiogram, nasal and oral
airﬂow (using oronasal ﬂow thermistor in the diagnostic study
and a piezoelectric pressure sensor to record mask pressure in
the therapeutic study), thoracic and abdominal effort (using
piezoelectric belts), limb movements (by means of EMG on
anterior tibialis muscle), pulse oximetry, body position
(recorded by a position sensor) and snoring sound level (by
means of a microphone placed externally to the trachea). On
CPAP titration, all patients received CPAP via an oronasal
mask which was selected individually. The auto mode of CPAP
device (Resmed, Autoset spiritTM) with a pressure range of
4–20 cm H2O was used for automatic titration in either of
the study groups.
Polysomnography scoring
The polysomnograms were scored manually according to
American academy of sleep medicine [5]. Obstructive apnea
was reported as a complete cessation of airﬂow for at least
10 s with a preserved respiratory effort. Hypopnea required
an event of at least 10 s duration in association with a
P30% drop in the baseline amplitude and a P4% desatura-
tion from the baseline saturation. The AHI was calculated as
the number of apnea and hypopnea events per hour of sleep.
Desaturation was detected by drop of at least 4% below base-
line. An arousal was deﬁned as an abrupt change in the EEG
frequency to alpha, theta, or faster frequency in non-rapid eye
movement (NREM) sleep with an increase in submental EMG
as well as in rapid eye movement (REM) lasting at least 3 s [9].
After manual scoring of the different previous variables, a
polysomnographic report was printed including data of sleep
[Total seep time (TST) in hours, sleep efﬁciency, sleep stages
%], respiratory [total, NREM and REM AHI and oxygen
indices (Desaturation index (DI), average oxygen level, mini-
mum oxygen level, time spent below 90% (T90)] parameters.
In CPAP titration report, data about different CPAP pressures
applied during the study were detected. The effective CPAP
pressure (Peff) was determined as the pressure that alleviated
apnoeas and hypopnea (AHI < 5). We considered titration
to be successful if the Peff could be obtained together with ade-
quate REM duration of at least 10 min [10].
Statistical analysis
Statistical Package for the Social Sciences (SPSS-version 16)
software was used for analysis of results. Results in this study
were presented in mean ± standard deviation or number and
Table 1 Demographic data of the study groups (n= 120).
Variable Full night study (n= 60) Split night study (n= 60) P-value
Age (mean ± SD) 52.70 ± 9.7 53.1 ± 11.5 0.385
Gender (%)
Male 34 (56.7%) 28 (46.7%)
Female 26 (43.3%) 32 (53.3%) 0.273
BMI (kg/m2) 39.4 ± 9.1 42.2 ± 14.8 0.223
Diagnostic polysomnography
AHI (event/h) 52.8 ± 27.9 53 ± 25.1 0.933
DI (event/h) 59.48 ± 30.7 59.1 ± 35.2 0.955
Average O2 (%) 86.39 ± 13.8 87.2 ± 8.3 0.931
Arousal index (event/h) 17.84 ± 11.72 20.5 ± 10.3 0.074
BMI: body mass index, AHI: apnea hypopnea index, DI: desaturation index.
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group or between baseline and CPAP, chi-square test was used
for analysis of qualitative data and independent sample stu-
dent t-test for analysis of quantitative data. To determine the
best cut-off for AHI and TST for optimum titration in the split
night group, we calculated the area under the receiver operat-
ing characteristic curve (AUC) and compared the AHI and
TST in those with successful titration with those with unsuc-
cessful titration. The difference was considered signiﬁcant
when p< 0.05.
Results
After randomization of all included patients, 60 patients in
each group (full night and split night group) were matched
for age, sex, BMI and disease severity. Demographic data of
the study groups are presented in Table 1.
Table 2 revealed the polysomnographic parameters of split
night group patients where there were signiﬁcantly shorterTable 2 Polysomnographic parameters of the split night group (n=
Variable Diagnostic part (n= 60)
Mean ± SD
Sleep parameters
TST (h) 3.3 ± 0.72
Sleep eﬃciency (%) 79 ± 16.8
Sleep onset latency (min) 2.56 ± 2.2
REM onset latency (min) 19.2 ± 22.29
Stage 1 (%) 24.7 ± 12.73
Stage 2 (%) 33.2 ± 14.1
Stage 3 (%) 17.7 ± 15.6
REM (%) 15.5 ± 15.2
Respiratory parameters
AHI (event/h) 53 ± 25.2
DI (event/h) 59 ± 35.2
Average O2 (%) 80.1 ± 8.26
Minimum O2 (%) 64.4 ± 15.7
T90 (min) 53.6 ± 42
Arousal index (event/h) 11.4 ± 10.3
TST = total sleep time, REM= rapid eye movement, AHI = apnea hyp
in minutes.
* Signiﬁcant.TST (2.3 ± 0.8 vs. 3.3 ± 0.72, p= 0.000) and prolonged sleep
onset latency (10.4 ± 26.9 vs. 2.56 ± 2.2, p= 0.013) during
CPAP titration compared to diagnostic part of the study.
Regarding sleep stages, there was signiﬁcant earlier REM
onset latency (10.40 ± 26.9 vs. 19.2 ± 22.29, p= 0.009) with
signiﬁcant increase in REM % TST (i.e. REM rebound)
(23.9 ± 8.7 vs. 15.5 ± 15.2) during titration but no signiﬁcant
change in other sleep stages from the diagnostic part of the
study. As expected, CPAP signiﬁcantly improved all respira-
tory parameters (p< 0.05). On comparing the CPAP titration
part with full night CPAP titration (Table 3), besides the
expected shorter TST (2.34 ± 0.82 vs. 4.023 ± 1.1,
p= 0.000), sleep efﬁciency (75.9 ± 15.7 vs. 81.5 ± 10.5,
p= 0.024) was signiﬁcantly shorter. As regards to sleep stages,
stage 1% TST was signiﬁcantly higher (22.3 ± 14 vs. 17.9
± 15.8, p= 0.013) but REM % TST (23.9 ± 18.7 vs. 31.3
± 14.8, p= 0.019) was signiﬁcantly lower. There were no sig-
niﬁcant differences in all respiratory parameters between the
two groups (p> 0.05).60).
CPAP part (n= 60)
Mean ± SD
P-value
2.3 ± 0.8 0.000*
75.9 ± 15.7 0.12
10.4 ± 26.9 0.013*
10.40 ± 26.9 0.009*
22.3 ± 14 0.456
34.53 ± 16.6 0.233
18.8 ± 12.27 0.189
23.9 ± 18.7 0.007*
7.9 ± 9.3 0.000*
14.5 ± 17.2 0.000*
88.6 ± 8.5 0.004*
77.9 ± 13.4 0.000*
8.4 ± 12.5 0.000*
7.6 ± 9.8 0.053*
opnea index, DI = desaturation index, T90 = time spent below 90%
Table 3 Polysomnographic parameters of the study groups on CPAP (n= 120).
Variable Full night study (n= 60)
Mean ± SD
Split night study (n= 60)
Mean ± SD
P-value
Sleep parameters
TST (h) 4.023 ± 1.1 2.34 ± 0.82 0.000*
Sleep eﬃciency (%) 81.5 ± 10.5 75.9 ± 15.7 0.024*
Sleep onset latency (min) 2.7 ± 3.8 10.4 ± 26.9 0.010*
REM onset latency (min) 10.31 ± 23.6 14.2 ± 22.3 0.354
Stage 1 (%) 17.9 ± 15.8 22.3 ± 14 0.013*
Stage 2 (%) 26.23 ± 14.2 34.53 ± 16.6 0.135
Stage 3 (%) 23.2 ± 14.9 18.8 ± 12.27 0.444
REM (%) 31.3 ± 14.8 23.9 ± 18.7 0.019*
Respiratory parameters
AHI (event/h) 7.67 ± 5.8 7.9 ± 9.4 0.834
DI (event/h) 10.03 ± 17.5 14.53 ± 17.2 0.158
Average O2 (%) 89.3 ± 7.7 88.6 ± 8.5 0.678
Minimum O2 (%) 72.43 ± 18 77.97 ± 13.4 0.079
T90 (min) 7.03 ± 12.88 8.46 ± 12.52 0.546
Arousal index (event/h) 7.44 ± 10.38 7.6 ± 9.8 0.93
CPAP titration
CPAP Peﬀ (cm H2O) 8.85 ± 2 8.88 ± 2.3 0.978
TST = total sleep time, REM= rapid eye movement, AHI = apnea hypopnea index, DI = desaturation index, T90 = time spent below 90%
in minutes, CPAP= continuous positive airway pressure, Peff = effective pressure.
* Signiﬁcant.
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CPAP titration was signiﬁcantly higher in split night group
than the full night group (30 (50%) vs. 16 (35.5%),
p= 0.025) (Fig. 1). Patients who could reach successful CPAP
titration during split night titration were signiﬁcantly less
obese (BMI was 36.3 ± 12.6 vs. 48 ± 14.6, p= 0.002) and
reported signiﬁcantly longer TST (2.8 ± 0.9 vs. 2 ± 0.6,
p= 0.001) and REM % TST (30.9 ± 16.1 vs. 16.9 ± 18.9,
p= 0.003) compared to those who could not reach successful
titration (Table 4).
To determine the optimum AHI and TST duration that was
needed for successful titration in split night sleep study, we
analyzed the data using the receiving operating characteristic
(ROC) curve. We identiﬁed AHI >36.4 as the optimum cut0%
10%
20%
30%
40%
50%
60%
70%
Successful titration U
Figure 1 Comparison between the split night group and the full night
patients (50%) in split night group vs. 16 patients (35.5%) in full nighoff for successful titration with AUC 0.5 (CI 95% [0.50–
0.80]) giving 73.5% sensitivity and 43.3% speciﬁcity (Fig. 2).
The patient should sleep more than 2.45 h to optimize success-
ful titration giving 74% sensitivity and 70% speciﬁcity with
AUC 0.7 (CI 95% [0.29–0.61]) (Fig. 3).
Discussion
Split-night polysomnography was introduced to obtain diag-
nosis and determine an effective CPAP on a single night that
would be convenient and cost effective. Underestimation of
the severity of sleep apnea (no or minimal REM sleep in the
ﬁrst half of the night) and inadequate time for CPAP titration
are potential disadvantages of this approach that may requirensuccessful titration
Full night group
Split night group
group regarding successful titration. Unsuccessful titration was 30
t group (p= 0.025).
Table 4 Possible factors associated with successful titration in split night group patients (n= 60).
Variable Successful titration (n= 30) Unsuccessful titration (n= 30) P-value
Age (mean ± SD) 55.73 ± 11.9 58.47 ± 11 0.362
Gender %
Male 12 (40.0%) 16 (53.3%) 0.301
Female 18 (56.2%) 14 (43.8%)
BMI (kg/m2) 36.3 ± 12.6 48 ± 14.6 0.002*
Diagnostic part of polysomnography
TST (h) 3.2 ± 0.7 3.4 ± 0.7 0.358
Stage 1 (%) 16.4 ± 9.4 25.1 ± 14.2 0.007
Stage 2 (%) 25.7 ± 12.8 26.7 ± 15.5 0.78
Stage 3 (%) 23.9 ± 15.6 21.6 ± 15.8 0.57
REM (%) 29.7 ± 18.2 23.3 ± 12.1 0.114
AHI (event/h) 47 ± 20.5 58.9 ± 28.2 0.05
DI (event/h) 58.27 ± 35.7 59.8 ± 35 0.862
Minimum O2 (%) 66.67 ± 15.5 62.13 ± 15.8 0.268
CPAP part of polysomnography
TST (h) 3.1 ± 0.9 2.15 ± 0.6 0.001*
Stage 1 (%) 32.4 ± 27.2 45.4 ± 30.1 0.085
Stage 2 (%) 17.2 ± 15.3 18.6 ± 16.5 0.722
Stage 3 (%) 18.9 ± 15.5 18.7 ± 20.9 0.961
REM (%) 30.9 ± 16.1 16.9 ± 18.9 0.003*
BMI: body mass index, TST = total sleep time, REM= rapid eye movement, AHI = apnea hypopnea index, DI = desaturation index.
* Signiﬁcant.
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ther increases the cost [7,8].
This study revealed that split night CPAP titration signiﬁ-
cantly improved all respiratory parameters which were compa-
rable to full night study; however, we did not report
improvement in sleep architecture during split night CPAP
titration. TST was signiﬁcantly shorter with signiﬁcant prolon-
gation in sleep and REM onset latency duration that might
reﬂect the inability to sleep following sleep disruption using
split night protocol. Similarly, Yamashiro et al. [11] showed
that there was a signiﬁcant reduction in AHI and percent
TST below 90% SaO2 during the split night CPAP comparedFigure 2 Area under receiving operating characteristic curve for
optimum baseline AHI needed for successful titration in split night
sleep study. AHI >36.4 identiﬁed the optimum cut off for
successful titration with AUC 0.5 (CI 95% [0.50–0.80]) giving
73.5% sensitivity and 43.3% speciﬁcity.with baseline; they suggested that a split-night protocol was as
effective as a second night in reducing apnea and hypopnea
index, improving oxygenation, and reducing arousals. To our
knowledge, there is no studies discussed the immediate effect
of split night CPAP titration on sleep architecture. However,
studies [12,13] that were carried out during full night CPAP
titration indicated that even short-term exposure to CPAP
improved sleep architecture with signiﬁcant decrease in light
sleep (stage 1 and stage 2) percent and signiﬁcant increase with
in both deep sleep (i.e. stage 3 and 4) and REM stage as a % of
total sleep time.
Although in this work we found that REM% TST was sig-
niﬁcantly increased during split night study compared to base-Figure 3 Area under receiving operating characteristic curve for
optimum TST (total sleep time) needed for successful titration in
split night sleep study. During CPAP titration, TST >2.45 h was
needed for successful titration with AUC 0.7 (CI 95% [0.29–0.61])
giving 74% sensitivity and 70% speciﬁcity.
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± 18.7 vs. 31.3 ± 14.8, p= 0.019). However, other studies
[3,14] reported adequate REM sleep during the titration por-
tion of their split-night study which was comparable to full
night study (24.1% vs. 22%). It is known that REM rebound
phenomenon (i.e. increase REM above baseline and normative
values) was an important phenomenon that usually occurred
following CPAP titration due to depletion of REM sleep in
OSA patients. It was considered a regulatory mechanism of
sleep homeostasis that returned sleep to normal architecture
after previous depletion of REM sleep. Both subjective
improvements in sleep quality and effective treatment of OSAS
patients were associated with REM sleep rebound following
the ﬁrst night of CPAP treatment [15,16].
When evaluating the adequacy of CPAP prescription by
comparing split-night versus full-night polysomnography, this
study achieved successful CPAP titration in 50% of patients
during split night study which was signiﬁcantly less than full
night titration (59.5% vs. 50%, p= 0.025) despite the effective
CPAP pressure being similar between the two groups. In a ret-
rospective review of 412 consecutive patients with an apnea
index P20/h, Iber and coworkers [17] found that 78% of the
CPAP titrations were adequate (the lower of AHI P20/h or
50% reduction during supine REM sleep). Yamashiro and
Kryger [11] found that patients with an AHI P40/h had sim-
ilar optimal pressures on a split-night and subsequent full-
night CPAP titration. Conversely, Okic et al. [18] in their study
of patients with severe OSA (AHI >40/h), split-night CPAP
titration resulted in a mean pressure 2.5 cm H2O higher than
that of full-night titration.
This study revealed that during split night titration part, the
more REM percentage was associated with successful CPAP
titration. Aldrich et al. have suggested that adequate split-
night studies should include REM sleep during CPAP titration
at the ﬁnal CPAP pressure [19]. On the other hand, in a split-
night study with successful titration, patients with REM
(n= 33) at ﬁnal pressure were comparable to patients without
REM (n= 8) regarding disease severity and CPAP use. They
suggested that the presence of REM sleep may not be neces-
sary for adequate CPAP pressure titration; but the authors
limited these results by the small numbers of patients studied
without REM [15].
On assessing the optimum AHI needed for successful titra-
tion in split night sleep study, we found diagnostic AHI
>36.5 as the optimum cut off for successful split night titra-
tion with AUC 0.5 (CI 95% [0.50–0.80]) giving 73.5% sensi-
tivity and 43.3% speciﬁcity and at least 2.75 h required for
CPAP titration. Strollo et al. required an AHI of >30 in
the diagnostic half of the split-night before proceeding to
CPAP titration [20]. Also Kushida and his colleagues have
suggested criteria for a split-night study: a minimum of 2 h
of diagnostic monitoring, AHI >40/h or 20 to 40/h with sev-
ere desaturation or other indications for an immediate titra-
tion, and 3 h remaining for the CPAP titration [21,22].
Medicare guidelines in some locales require at least 2 h of
sleep during the diagnostic portion [23]. More recently,
Khawaja et al. [24] showed that AHI derived from the ﬁrst
2 or 3 h of sleep was of sufﬁcient diagnostic accuracy to
rule-in OSA at an AHI threshold of 5 in patients suspected
of having OSA but that study did not assess adequate titra-
tion at this level of AHI.Conclusion
Split night sleep study is more commonly associated with
unsuccessful CPAP titration than full night titration but suc-
cessful titration could be obtained during split night titration
in patients with severe AHI >36.5 event/h.Conﬂict of interest
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